Christoph H. Westphal's most recent trade in Tscan Therapeutics Inc was a trade of 1,145,505 Voting Common Stock done . Disclosure was reported to the exchange on July 20, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tscan Therapeutics Inc | Christoph H. Westphal | Ten Percent Owner | 20 Jul 2021 | 1,145,505 | 1,145,505 | - | - | Voting Common Stock | ||
| Tscan Therapeutics Inc | Christoph H. Westphal | Ten Percent Owner | 20 Jul 2021 | 641,848 | 0 | - | - | Series A Preferred Stock | ||
| Tscan Therapeutics Inc | Christoph H. Westphal | Ten Percent Owner | 20 Jul 2021 | 332,594 | 0 | - | - | Series B Preferred Stock | ||
| Tscan Therapeutics Inc | Christoph H. Westphal | Ten Percent Owner | 20 Jul 2021 | 171,063 | 0 | - | - | Series C Preferred Stock | ||
| Tscan Therapeutics Inc | Christoph H. Westphal | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 20 Jul 2021 | 133,333 | 1,278,838 | - | 15 | 1,999,995 | Voting Common Stock |